Log In
BCIQ
Print this Print this
 

ET1502

  Manage Alerts
Collapse Summary General Information
Company Eureka Therapeutics Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today